RBC Capital Decreases Qiagen PT To $18

RBC Capital announced today that it has decreased its PT of Qiagen QGEN to $18, down from its previous PT of $20.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst RatingsHealth CareLife Sciences Tools & ServicesQiagenRBC Capital
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!